Effective intralesional combination 5-fluorouracil and triamcinolonetherapy for eruptive lower extremity atypical squamous proliferationsinduced by immune checkpoint inhibitor
Dermatology Online Journal · 06.07.2026 · 32 (3)
DOI: 10.25251/80y9k521 ↗Kurz gefasst
Fallbericht in der Zeitschrift Dermatology Online Journal, online erschienen am 06.07.2026. Verfasst von Angel Ray Baroz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Penn State College of Medicine, Hershey, PA, USA. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We report successful treatment of eruptive lower extremity atypical squamous proliferations occurring during cemiplimab therapy using serial intralesional 5-fluorouracil and triamcinolone, resulting in marked lesion regression.This case demonstrates that localized, non-surgical treatment strategies may provide effective disease control when systemic therapies or surgery are contraindicated or poorly tolerated.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Penn State College of Medicine, Hershey, PA, USA.
- Department of Dermatology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA.
Zitieren
APA
Baroz, A. R., Patel, B. M., Cartee, T., & Helm, T. N. (2026). Effective intralesional combination 5-fluorouracil and triamcinolonetherapy for eruptive lower extremity atypical squamous proliferationsinduced by immune checkpoint inhibitor. Dermatology Online Journal, 32(3). https://doi.org/10.25251/80y9k521
Vancouver
Baroz AR, Patel BM, Cartee T, Helm TN. Effective intralesional combination 5-fluorouracil and triamcinolonetherapy for eruptive lower extremity atypical squamous proliferationsinduced by immune checkpoint inhibitor. Dermatology Online Journal. 2026;32(3). doi:10.25251/80y9k521
BibTeX
@article{Baroz2026,
author = {Baroz, Angel Ray and Patel, Bansri M and Cartee, Todd and Helm, Thomas N},
title = {Effective intralesional combination 5-fluorouracil and triamcinolonetherapy for eruptive lower extremity atypical squamous proliferationsinduced by immune checkpoint inhibitor},
journal = {Dermatology Online Journal},
year = {2026},
volume = {32},
number = {3},
doi = {10.25251/80y9k521}
}
EUVIMED